Vadivarhe Speciality Chemicals Ltd.
NNSE:VSCL24.50
INR
-0.40
(-1.61%)
Vadivarhe Speciality Chemicals Ltd.
NSE:VSCL
(National Stock Exchange of India)
Recent
price
24.50
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.- Similar Companies
- Business
- Vadivarhe Speciality Chemicals Limited is an India-based specialty chemical and pharmaceutical manufacturing company that develops, produces, and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty fine chemicals, and personal care ingredients, alongside offering custom research and manufacturing services (CRAMS). The company's core product and service portfolio encompasses multiple specialized categories: Active Pharmaceutical Ingredients, including Phenylephrine Hydrochloride, Dicyclomine Hydrochloride, Isoxsuprine Hydrochloride, and related therapeutic compounds for respiratory, gastrointestinal, and cardiovascular applications; Pharmaceutical Intermediates, comprising pyridine derivatives, piperidines, aromatic building blocks, and custom organic synthesis intermediates for generic pharmaceutical formulators; Specialty and Fine Chemicals, featuring high-purity chemical reagents, alkylated aromatic intermediates, and specialized process chemicals for agrochemical, industrial, and material science sectors; Personal Care Ingredients, including antiseptic agents, skin-conditioning ingredients, cosmetic additives, and specialty botanical formulations; and Contract Research and Manufacturing Services (CRAMS), encompassing route scouting, process chemistry development, analytical testing, process optimization, scale-up synthesis, and commercial-scale toll manufacturing. Founded in 2009 and headquartered in Nashik, Maharashtra, India, the company operates manufacturing plants and research facilities situated in Vadivarhe, Igatpuri, Maharashtra, distributing its product lines across the domestic Indian market and exporting to international markets throughout Europe, North America, Latin America, the Middle East, and the Asia-Pacific region. In recent developments, Vadivarhe Speciality Chemicals has undertaken an operational restructuring and corporate reorganization following resolution proceedings, resulting in reconstituted management oversight, balance sheet restructuring, and targeted capital deployment. The company has advanced the modernization of its manufacturing infrastructure, upgraded its environmental compliance systems including effluent management and zero liquid discharge capabilities, resumed commercial operations across key synthesis blocks, expanded its custom synthesis pipeline with multinational pharmaceutical partners, and initiated regulatory filing enhancements to broaden its penetration in regulated global API markets.